ALAB PE Ratio & Valuation, Is ALAB Overvalued

Historical Valuation

Astera Labs, Inc (ALAB) is now in the Fair zone, suggesting that its current forward PE ratio of 85.47 is considered Fairly compared with the five-year average of 94.16. The fair price of Astera Labs, Inc (ALAB) is between 136.60 to 269.02 according to relative valuation method.

Relative Value

Fair Zone

136.60-269.02

Current Price：199.79

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Astera Labs, Inc (ALAB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Astera Labs, Inc (ALAB) has a current Price-to-Book (P/B) ratio of 22.45. Compared to its 3-year average P/B ratio of 16.06, the current P/B ratio is approximately 39.81% higher. Relative to its 5-year average P/B ratio of 16.06, the current P/B ratio is about 39.81% higher. Astera Labs, Inc (ALAB) has a Forward Free Cash Flow (FCF) yield of approximately 1.02%. Compared to its 3-year average FCF yield of 0.68%, the current FCF yield is approximately 49.56% lower. Relative to its 5-year average FCF yield of 0.68%, the current FCF yield is about 49.56% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ALAB competitors is 7.23, providing a benchmark for relative valuation. Astera Labs, Inc Corp (ALAB.O) exhibits a P/S ratio of 15.38, which is 112.64% above the industry average. Given its robust revenue growth of 93.40%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ALAB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ALAB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ALAB currently overvalued or undervalued?

What is Astera Labs, Inc (ALAB) fair value?

ALAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Astera Labs, Inc (ALAB) is between 136.60 to 269.02 according to relative valuation method.

How does ALAB's valuation metrics compare to the industry average?

The average P/S ratio for ALAB's competitors is 7.23, providing a benchmark for relative valuation. Astera Labs, Inc Corp (ALAB) exhibits a P/S ratio of 15.38, which is 112.64% above the industry average. Given its robust revenue growth of 93.40%, this premium appears sustainable.

What is the current P/B ratio for Astera Labs, Inc (ALAB) as of May 11 2026?

As of May 11 2026, Astera Labs, Inc (ALAB) has a P/B ratio of 22.45. This indicates that the market values ALAB at 22.45 times its book value.

What is the current FCF Yield for Astera Labs, Inc (ALAB) as of May 11 2026?

As of May 11 2026, Astera Labs, Inc (ALAB) has a FCF Yield of 1.02%. This means that for every dollar of Astera Labs, Inc's market capitalization, the company generates 1.02 cents in free cash flow.

What is the current Forward P/E ratio for Astera Labs, Inc (ALAB) as of May 11 2026?

As of May 11 2026, Astera Labs, Inc (ALAB) has a Forward P/E ratio of 85.47. This means the market is willing to pay $85.47 for every dollar of Astera Labs, Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Astera Labs, Inc (ALAB) as of May 11 2026?

As of May 11 2026, Astera Labs, Inc (ALAB) has a Forward P/S ratio of 15.38. This means the market is valuing ALAB at $15.38 for every dollar of expected revenue over the next 12 months.

ALAB Valuation